SS Innovations International (SSII) Non Operating Income (2016 - 2026)
SS Innovations International (SSII) reported Non Operating Income of $207538.0 for Q1 2026, down 13.71% on a YoY basis from $240500.0 in Q1 2025, and up 609.05% sequentially from $29270.0 in Q4 2025.
SS Innovations International (SSII) Non Operating Income (2016 - 2026) Analysis & Trends
SS Innovations International (SSII) has 11 years of Non Operating Income data on file, last reported at $207538.0 in Q1 2026.
- For the quarter ending Q1 2026, Non Operating Income fell 13.71% year-over-year to $207538.0; the trailing twelve-month figure through Mar 2026 stood at $201198.0 (up 169.34% YoY), and the FY2025 full-year result was $33087.0, up 118.88% from the prior year.
- Non Operating Income advanced to $207538.0 in Q1 2026, from $29270.0 in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $240500.0 in Q1 2025 to a low of -$333353.0 in Q2 2023.
- A 5-year average of -$33938.2 and a median of -$35634.0 in 2025 frame the typical range for Non Operating Income.
- Across the five-year window, Non Operating Income sank 692634.29% in 2023 and surged 2649.29% in 2025, its largest moves.
- Tracing SSII's Non Operating Income over 5 years: stood at -$151186.0 in 2022, then soared by 111.82% to $17870.0 in 2023, then tumbled by 574.01% to -$84705.0 in 2024, then soared by 134.56% to $29270.0 in 2025, then jumped by 609.05% to $207538.0 in 2026.
- Business Quant data shows SSII's Non Operating Income at $207538.0 in Q1 2026, $29270.0 in Q4 2025, and -$35634.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 62.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -18.60 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | SS Innovations International | 699.75 Mn | 676.14 Mn | 5.33 Mn | 207,538.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 207,538.00 |
| Dec 31, 2025 | 29,270.00 |
| Sep 30, 2025 | -35,634.00 |
| Jun 30, 2025 | 24.00 |
| Mar 31, 2025 | 240,500.00 |
| Dec 31, 2024 | -84,705.00 |
| Sep 30, 2024 | -40,715.00 |
| Jun 30, 2024 | -40,381.00 |
| Mar 31, 2024 | -9,434.00 |
| Dec 31, 2023 | 17,870.00 |
| Sep 30, 2023 | -46,438.00 |
| Jun 30, 2023 | -333,353.00 |
| Mar 31, 2023 | -242,387.00 |
| Dec 31, 2022 | -151,186.00 |
| Sep 30, 2022 | -60,983.00 |
| Jun 30, 2022 | -26,971.00 |
| Mar 31, 2022 | 35.00 |
| Dec 31, 2021 | -77,363.00 |
| Sep 30, 2021 | 29.00 |
| Jun 30, 2021 | 38.00 |